Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/1999
06/01/1999US5908851 Derivatives of succinamide and their use as metalloproteinase inhibitor
06/01/1999US5908849 Anti-oxidant esters of non-steroidal anti-inflammatory agents
06/01/1999US5908848 Analgesics
06/01/1999US5908843 Thrombosis, antiinflammatory agent, arteriosclerosis, antitumor agents
06/01/1999US5908837 Antiinflammatory agent
06/01/1999US5908833 Glucocorticosteroid chemically bound to a sugar
06/01/1999US5908827 Protein from urine named component B
06/01/1999CA1340567C Heterocyclic amide derivatives
05/1999
05/27/1999WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
05/27/1999WO1999025697A1 Novel pyridazine derivatives and drugs containing the same as the active ingredient
05/27/1999WO1999025695A1 5-arylpyrazole compounds
05/27/1999WO1999025693A1 Metalloproteinase inhibitors
05/27/1999WO1999025687A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/27/1999WO1999025686A1 Cyclic amine derivatives and their use as drugs
05/27/1999WO1999025372A1 Small peptides and methods for treatment of asthma and inflammation
05/27/1999WO1999025359A1 New composition of matter
05/27/1999WO1999014346A3 SENSE mRNA THERAPY
05/27/1999WO1999012529A3 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
05/27/1999WO1999010480A3 New tissue-specific calpaines, their production and their use
05/27/1999WO1999010371A3 Cyclopeptide derivatives as adhesion inhibitors
05/27/1999CA2306460A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/26/1999EP0918059A1 Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
05/26/1999EP0917572A2 Secreted proteins and polynucleotides encoding them
05/26/1999EP0917463A2 Tramadol multiple unit formulations
05/26/1999EP0917462A1 Cell adhesion inhibitors
05/26/1999EP0917427A1 Teat dipping agent
05/26/1999EP0804459A4 Therapeutic compound - fatty acid conjugates
05/26/1999EP0752991B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONES ANTAGONISTS OF AMPA AND NMDA RECEPTORS
05/26/1999EP0752988B1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES ANTAGONISTS OF AMPA AND NMDA RECEPTORS
05/26/1999EP0610290B1 Manufacture of a medicament for treatment of ocular inflammation by blockage of cell adhesion molecules
05/26/1999CN1217714A Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF)
05/26/1999CN1217332A Metal protease inhibitor, preparation method therefor and medicinal composition containing same
05/26/1999CN1217202A Medicine for treating rheumatic diseases
05/25/1999US5907043 Coupling n-(4-methoxybenzoyl)-l-valyl-l-proline or a salt with 3-amino-4-methyl-1,1,1-trifluoro-2-pentanol forming (s)-1-(s)-2-(4-methoxybenzamido)-3-(2,2,2-trifluoro-1-hydroxy ethyl)propyl)pyrrolidine-2-carboxamide, oxidizing the product
05/25/1999US5907038 Azepanes
05/25/1999US5906977 Conjugate for treating inflammatory diseases
05/25/1999US5906820 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis
05/25/1999US5906812 Useful for treating intrisic and extrinsic aging such as wrinkles, fine lines, actinic blemishes, dyschromias, dermatitis or scars in human skin; cosmetics
05/20/1999WO1999024469A1 Secreted proteins and polynucleotides encoding them
05/20/1999WO1999024460A2 Dipeptide nitriles
05/20/1999WO1999024422A1 Azaring-ether derivatives and their use as nicotinic ach receptor modulators
05/20/1999WO1999024420A1 Pyrimidinone compounds and pharmaceutical compositions containing them
05/20/1999WO1999024419A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024416A1 Aminothiazole inhibitors of cyclin dependent kinases
05/20/1999WO1999024408A1 Heterocyclic compounds having mmp and tnf inhibitory activity
05/20/1999WO1999024406A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
05/20/1999WO1999024405A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type
05/20/1999WO1999024404A1 Substituted pyridine compounds as anti-inflammatory agents
05/20/1999WO1999024399A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024398A2 Urea derivatives and their use as integrin inhibitors
05/20/1999WO1999024052A2 Use of protein h as cytostatic agent
05/20/1999WO1999024035A1 Benzothiazole protein tyrosine kinase inhibitors
05/20/1999WO1999024024A2 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
05/20/1999WO1999015653A3 Tie ligand homologues
05/20/1999WO1999015503A3 Process for making diaryl pyridines useful as cox-2 inhibitors
05/20/1999WO1999015160A3 Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies
05/20/1999WO1999011666B1 N-terminal modifications of rantes and methods of use
05/20/1999WO1999009182A3 Rab proteins
05/20/1999CA2309319A1 Benzothiazole protein tyrosine kinase inhibitors
05/20/1999CA2309177A1 Pyrimidinone compounds and pharmaceutical compositions containing them
05/20/1999CA2309121A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
05/20/1999CA2309007A1 Secreted proteins and polynucleotides encoding them
05/20/1999CA2308716A1 Urea derivatives and their use as integrin inhibitors
05/20/1999CA2308586A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type
05/20/1999CA2308361A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999CA2308359A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999CA2308358A1 Heterocyclic compounds having mmp and tnf inhibitory activity
05/20/1999CA2306477A1 Azaring-ether derivatives and their use as nicotinic ach receptor modulators
05/19/1999EP0916673A1 6-Amino purine derivatives having PDE-IV inhibition activity
05/19/1999EP0916672A1 6-Amino purine derivatives having PDE-IV inhibition activity and intermediates
05/19/1999EP0916671A1 Metalloprotease inhibitors, process for their preparation and pharmaceutical compositions containing them
05/19/1999EP0916666A1 3-alkyloxy-,aryloxy-, or arylalkyloxy-benzo[b]thiophene-2-carboxamides as inhibitors of cell adhesion
05/19/1999EP0916663A1 18Beta, 19Beta-diacetyloxy-18Alpha, 19Alpha-epoxy-3,13(16), 14-clerodatrien-2-one (Esculentin A) and 18Beta, 19Beta-diacetyloxy-18Alpha, 19Alpha-epoxy-3, 12, 14-clerodatrien-2Beta-isovaleryloxy-6Beta, 7Alpha-diol (Esculentin B), a process for their preparation, and their use in the manufacture of medicaments
05/19/1999EP0915974A1 Modified tie-2-receptor ligands
05/19/1999EP0915879A1 Novel compounds
05/19/1999EP0915857A1 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals
05/19/1999EP0915850A1 Novel carbocyclic diarylmethylene derivatives, methods for preparing same, and therapeutical uses thereof
05/19/1999EP0915848A1 1,2-diarylindole as cox-2 inhibitors
05/19/1999EP0915843A1 Azetidinone derivatives for the treatment of atheroscleroses
05/19/1999EP0915700A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
05/19/1999EP0915698A1 Therapeutic treatment for vegf related diseases
05/19/1999EP0745596B1 Heteroaromatic oxazole compounds and use thereof
05/19/1999CN1217025A Processed polypeptides with IL-16 activity, process for preparing same and their use
05/19/1999CN1217024A Chemokine alpha 2
05/19/1999CN1216994A Apoptosis inducing molecule II
05/19/1999CN1216993A Alkyl-4-silyl-phenols and esters thereof as anti-atherosclerotic agent
05/19/1999CN1216980A Triaryl compounds
05/19/1999CN1216978A New vitamin-D derivatives with carbo- or heterocyclic substitutents at C-25, process for the prodn. intermediate products and their use for producing medicaments
05/19/1999CN1216921A Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
05/19/1999CN1216767A Novel 5-membered ring heterocycles, their prepn. their use and pharmaceutical preparations comprising them
05/19/1999CN1216762A 2-(arylphenyl) amino-imidazoline derivatives
05/19/1999CN1043424C Quaternary nitrogen contg. phosphonate compounds, pharmaceutical compositions and pharmaceutical use
05/19/1999CN1043405C Method for prepn. of pharmaceutical compositions contg. heterocyclic amide derivatives
05/18/1999US5905083 Method of treating rheumatoid arthritis
05/18/1999US5905081 Topical formulations of azathioprine to treat inflammatory bowel disorders
05/18/1999US5904937 Taste masked pharmaceutical compositions
05/18/1999US5904932 Topical preparation containing a suspension of solid lipid particles
05/18/1999US5904921 Stabilized compositions of superoxide dismutase obtained from germinated plant seeds
05/18/1999CA2109744C 1-phenylbicyclo¬2.2.2|octane derivatives, a process for their preparation and pharmaceutical compositions holding same
05/18/1999CA1340543C Pharmaceutically active compounds
1 ... 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 ... 1272